Clinical and Molecular Hepatology (Oct 2020)
Phosphoinositide 3-kinase inhibitors are effective therapeutic drugs for the treatment of hepatocellular carcinoma?
Abstract
No abstracts available.Keywords
Clinical and Molecular Hepatology (Oct 2020)